AVLN · Avalyn Pharma Inc. · Debt
Market Cap
$1.53B
Shares
44.33M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1540171
CUSIP
05348Y105
13F (30d)
68 filings
68 filers
Visit website
Investor relations